




Proton-Pump-Inhibitors-Modulators-MCE.docx 免費下載
版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html Proton HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html PumpProton pump is an integral membrane protein that is capable of moving protons across a biological membrane. Mechanisms areb
2、ased on conformational changes of the protein structure or on theQ cycle. In cell respiration, the proton pump uses energy totransport protons from the matrix of the mitochondrion to the inter-membrane space. It is an active pump, that generates aprotonconcentration gradient across the inner mitocho
3、ndrial membrane, because there are more protons outside the matrix thaninside. The difference in pH and electric charge (ignoring differences inbuffer capacity) creates an electrochemical potentialdifference that works similar to that of a battery or energy storing unit for the cell. The process cou
4、ld also be seen as analogous tocycling uphill or charging a battery for later use, as it produces potential energy. The proton pump does not create energy, butforms a gradient that stores energy for later use.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html Proton HYPERLINK http
5、s:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html Pump HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.M
6、edChemE/Targets/Proton Pump.html Antagonists HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html & HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html HYPERLINK https:/www.MedChemE/Targets/Proton Pump.html Activators HYPERLINK https:/www.M
7、edChemE/_R_-Lansoprazole.html (R)-Lansoprazole(Dexlansoprazole) Cat. No.: HY-13662B HYPERLINK https:/www.MedChemE/r-lansoprazole-d4.html (R)-Lansoprazole-d4(Dexlansoprazole-d4) Cat. No.: HY-13662BS(R)-Lansoprazole is the R enantiomer ofLansoprazole, Lansoprazole (AG 1749) is an orallyactive proton p
8、ump inhibitor which prevents thestomach from producing acid.(R)-Lansoprazole-d4 is deuterium labeled(R)-Lansoprazole. (R)-Lansoprazole is the Renantiomer of Lansoprazole, Lansoprazole (AG 1749)is an orally active proton pump inhibitor whichprevents the stomach from producing acid.Purity: 95.04%Clini
9、cal Data: LaunchedSize: 10 mM 1 mL, 100 mg, 500 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/racemic-vasicine.html ()-Vasicine()-Peganine) Cat. No.: HY-N7031 HYPERLINK https:/www.MedChemE/5-hydroxylansoprazole.html 5-Hydroxylansoprazole(AG1908) Ca
10、t. No.: HY-118283()-Vasicine is the racemate of Vasicine. Vasicine(Peganine) significantly inhibits H+-K+-ATPaseactivity in vitro with an IC of5073.47 g/mL. Anti-ulcer activity. Vasicineshows significant anti-secretory, antioxidantand cytoprotective effect.5-Hydroxylansoprazole (AG1908) is an active
11、metabolite of Lansoprazole in plasma. Lansoprazoleis metabolized by CYP2C19 forming5-Hydroxylansoprazole. Lansoprazole is a gastricproton-pump inhibitor and is effective in thetreatment of various peptic diseases.Purity: 99.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mgPurity: 98%Clinical
12、 Data: No Development ReportedSize: 1 mg HYPERLINK https:/www.MedChemE/abeprazan.html Abeprazan(DWP14012; Fexuprazan) Cat. No.: HY-109079 HYPERLINK https:/www.MedChemE/abeprazan-hydrochloride.html Abeprazan HYPERLINK https:/www.MedChemE/abeprazan-hydrochloride.html HYPERLINK https:/www.MedChemE/abep
13、razan-hydrochloride.html hydrochloride(DWP14012 hydrochloride; Fexuprazan hydrochloride) Cat. No.: HY-109079AAbeprazan (DWP14012) is a potassium-competitiveacid blocker. Abeprazan inhibits H+, K+- ATPaseby reversible potassium-competitive ionic bindingwith no acid activation required.Abeprazan hydro
14、chloride (DWP14012 hydrochloride)is a potassium-competitive acid blocker.Abeprazan hydrochloride inhibits H+, K+- ATPaseby reversible potassium-competitive ionic bindingwith no acid activation required.Purity: 99.58%Clinical Data: Phase 3Size: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Dat
15、a: Phase 3Size: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/abscisic-acid.html Abscisic HYPERLINK https:/www.MedChemE/abscisic-acid.html HYPERLINK https:/www.MedChemE/abscisic-acid.html acid HYPERLINK https:/www.MedChemE/abscisic-acid.html HYPERLINK https:/www.MedChemE/Bafilomycin_A1.html Bafilomycin H
16、YPERLINK https:/www.MedChemE/Bafilomycin_A1.html HYPERLINK https:/www.MedChemE/Bafilomycin_A1.html A1(S)-(+)-Abscisic acid; ABA) Cat. No.: HY-100560Cat. No.: HY-100558Abscisic acid (S)-(+)-Abscisic acid), an orallyactive phytohormone in fruits and vegetables, isan endogenously produced mammalian hor
17、mone.Abscisic acid is a growth inhibitor and canregulate many aspects of plant growth anddevelopment.Bafilomycin A1 is a specific and reversibleinhibitor of vacuolar H+-ATPase (V-ATPase) withIC values of 4-400 nmol/mg. Bafilomycin A1, a50macrolide antibiotic, is also used as anautophagy inhibitor at
18、 the late stage.Purity: 99.88%Clinical Data: Phase 4Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mgPurity: 99.43%Clinical Data: No Development ReportedSize: 100 g, 500 g, 1 mg, 5 mg HYPERLINK https:/www.MedChemE/caloxin-2a1.html Caloxin HYPERLINK https:/www.MedChemE/caloxin-2a1.html HYPERLINK https:/www.MedChe
19、mE/caloxin-2a1.html 2A1 HYPERLINK https:/www.MedChemE/caloxin-2a1.html HYPERLINK https:/www.MedChemE/caloxin-2a1-tfa.html Caloxin HYPERLINK https:/www.MedChemE/caloxin-2a1-tfa.html HYPERLINK https:/www.MedChemE/caloxin-2a1-tfa.html 2A1 HYPERLINK https:/www.MedChemE/caloxin-2a1-tfa.html HYPERLINK htt
20、ps:/www.MedChemE/caloxin-2a1-tfa.html TFACat. No.: HY-P3278 Cat. No.: HY-P3278ACaloxin 2A1 is an extracellular plasma membraneCa2+-ATPase (PMCA) peptide inhibitor. Caloxin2A1 does not affect basal Mg2+-ATPase orNa+-K+-ATPase.Caloxin 2A1 TFA is an extracellular plasmamembrane Ca2+-ATPase (PMCA) pepti
21、de inhibitor.Caloxin 2A1 TFA does not affect basalMg2+-ATPase or Na+-K+-ATPase.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.69%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg, 50 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLIN
22、K https:/www.MedChemE/Chebulinic-acid.html Chebulinic HYPERLINK https:/www.MedChemE/Chebulinic-acid.html HYPERLINK https:/www.MedChemE/Chebulinic-acid.html acidCat. No.: HY-N2033 HYPERLINK https:/www.MedChemE/concanamycin-a.html Concanamycin HYPERLINK https:/www.MedChemE/concanamycin-a.html HYPERLIN
23、K https:/www.MedChemE/concanamycin-a.html A(Antibiotic X 4357B; Concanamycin; X 4357B) Cat. No.: HY-N1724Chebulinic acid is a potent natural inhibitor ofM. tuberculosis DNA gyrase, also can inhibitSMAD-3 phosphorylation, inhibit H+ K+-ATPaseactivity.Concanamycin A (Antibiotic X 4357B) is a macrolide
24、antibiotic and a specific vacuolar type H+-ATPase(V-ATPase) inhibitor.Purity: 99.42%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mgPurity: 97.84%Clinical Data: No Development ReportedSize: 25 g, 50 g HYPERLINK https:/www.MedChemE/diphyllin.html Diphyllin HYPERLINK https:/www.MedC
25、hemE/diphyllin.html HYPERLINK https:/www.MedChemE/en6.html EN6Cat. No.: HY-N2532 Cat. No.: HY-128892Diphyllin is an arylnaphthalene lignan isolatedfrom Justicia procumbens and is a potent HIV-1inhibitor with an IC50 of 0.38 M. Diphyllin isactive against vesicular stomatitis virus (VSV)and influenza
26、virus.EN6 is a small-molecule in vivo activator ofautophagy that covalently targets cysteine 277 inthe ATP6V1A subunit of the lysosomal the vacuolarH+ ATPase (v-ATPase).Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mg, 25 mgPurity: 99.16%Clinical Data:Size: 10 mM 1 mL, 1 mg, 5 mg, 10
27、mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/Esomeprazole_magnesium.html Esomeprazole HYPERLINK https:/www.MedChemE/Esomeprazole_magnesium.html HYPERLINK https:/www.MedChemE/Esomeprazole_magnesium.html magnesium(S)-Omeprazole magnesium; (-)-Omeprazole magnesium) Cat. No.: HY-B1446 HYPERLINK https
28、:/www.MedChemE/esomeprazole-magnesium-salt.html Esomeprazole HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-salt.html HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-salt.html magnesium HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-salt.html HYPERLINK https:/www.MedChemE/esomeprazo
29、le-magnesium-salt.html salt HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-salt.html (S)-Omeprazole magnesium salt;(-)-Omeprazole magnesium salt) Cat. No.: HY-17021AEsomeprazole magnesium (S)-Omeprazole magnesium)is a potent and orally active H+, K+-ATPaseinhibitor. Esomeprazole magnesium has
30、thepotential for upper intestinal disorders andgastroesophageal reflux disease research.Esomeprazole magnesium salt (S)-Omeprazolemagnesium salt) is a potent and orally activeproton pump inhibitor and reduces acid secretionthrough inhibition of the H+, K+-ATPase ingastric parietal cells.Purity: 98.0
31、%Clinical Data: LaunchedSize: 10 mM 1 mL, 50 mgPurity: 98%Clinical Data: LaunchedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-trihydrate.html Esomeprazole HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-trihydrate.html HYPERLINK https:/www.MedChemE/esomeprazole-magnesiu
32、m-trihydrate.html magnesium HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-trihydrate.html HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-trihydrate.html trihydrate HYPERLINK https:/www.MedChemE/esomeprazole-magnesium-trihydrate.html (S)-Omeprazole magnesium HYPERLINK https:/www.MedChemE
33、/Esomeprazole-potassium-salt.html Esomeprazole HYPERLINK https:/www.MedChemE/Esomeprazole-potassium-salt.html HYPERLINK https:/www.MedChemE/Esomeprazole-potassium-salt.html potassium HYPERLINK https:/www.MedChemE/Esomeprazole-potassium-salt.html HYPERLINK https:/www.MedChemE/Esomeprazole-potassium-s
34、alt.html salt HYPERLINK https:/www.MedChemE/Esomeprazole-potassium-salt.html (S)-Omeprazole potassium salt;trihydrate; (-)-Omeprazole magnesium trihydrate) Cat. No.: HY-17022 (-)-Omeprazole potassium salt) Cat. No.: HY-17021BEsomeprazole magnesium trihydrate (S)-Omeprazolemagnesium trihydrate) is a
35、potent and orallyactive H+, K+-ATPase inhibitor. Esomeprazolemagnesium trihydrate has the potential for upperintestinal disorders and gastroesophageal refluxdisease research.Esomeprazole potassium salt (S)-Omeprazolepotassium salt) is a potent and orally activeproton pump inhibitor and reduces acid
36、secretionthrough inhibition of the H+, K+-ATPase ingastric parietal cells.Purity: 95.79%Clinical Data: LaunchedSize: 50 mg, 100 mg, 200 mg, 500 mgPurity: 98%Clinical Data: LaunchedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Esomeprazole-sodium.html Esomeprazole HYPERLINK https:/www.MedChemE/Esome
37、prazole-sodium.html HYPERLINK https:/www.MedChemE/Esomeprazole-sodium.html sodium HYPERLINK https:/www.MedChemE/Esomeprazole-sodium.html HYPERLINK https:/www.MedChemE/esomeprazole-d3.html Esomeprazole-d3(S)-Omeprazole sodium; (-)-Omeprazole sodium) Cat. No.: HY-17023Cat. No.: HY-17021S1Esomeprazole
38、sodium (S)-Omeprazole sodium) is apotent and orally active proton pumpinhibitor. Esomeprazole reduces acid secretionthrough inhibition of the H+, K+-ATPase ingastric parietal cells.Esomeprazole-d3 is deuterium labeled Esomeprazole.Esomeprazole (S)-Omeprazole) is a potent andorally active proton pump
39、 inhibitor and reducesacid secretion through inhibition of the H+,K+-ATPase in gastric parietal cells.Purity: 99.80%Clinical Data: LaunchedSize: 10 mg, 50 mg, 100 mg, 250 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/esomeprazole-d3-s
40、odium.html Esomeprazole-d3 HYPERLINK https:/www.MedChemE/esomeprazole-d3-sodium.html HYPERLINK https:/www.MedChemE/esomeprazole-d3-sodium.html sodiumCat. No.: HY-17021S HYPERLINK https:/www.MedChemE/Ilaprazole.html Ilaprazole(IY-81149) Cat. No.: HY-101664Esomeprazole-d3 sodium is the deuterium label
41、edEsomeprazole. Esomeprazole (S)-Omeprazole) is apotent and orally active proton pump inhibitor andreduces acid secretion through inhibition of theH+, K+-ATPase in gastric parietal cells.Ilaprazole (IY-81149) is an orally active protonpump inhibitor. Ilaprazole irreversiblyinhibits H+/K+-ATPase in a
42、 dose-dependentmanner with an IC of pump inhibitory activity of506 M in rabbit parietal cell preparation.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: LaunchedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/ilaprazole-sodi
43、um.html Ilaprazole HYPERLINK https:/www.MedChemE/ilaprazole-sodium.html HYPERLINK https:/www.MedChemE/ilaprazole-sodium.html sodium(IY-81149 sodium) Cat. No.: HY-B2145 HYPERLINK https:/www.MedChemE/km91104.html KM91104Cat. No.: HY-135474Ilaprazole (IY-81149) sodium is an orally activeproton pump inh
44、ibitor. Ilaprazole sodiumirreversibly inhibits H+/K+-ATPase in adose-dependent manner with an IC of 6 M in50rabbit parietal cell preparation.KM91104, a cell-permeable V-ATPase inhibitor,specifically targets the a3-b2 subunits ofV-ATPase.Purity: 98.50%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10
45、 mg, 25 mg, 50 mg, 100 mgPurity: 99.64%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/lansoprazole.html Lansoprazole(AG-1749) Cat. No.: HY-13662 HYPERLINK https:/www.MedChemE/lansoprazole-sulfide-d4.html Lansoprazole HYPERLINK https:/www.MedChemE
46、/lansoprazole-sulfide-d4.html HYPERLINK https:/www.MedChemE/lansoprazole-sulfide-d4.html Sulfide HYPERLINK https:/www.MedChemE/lansoprazole-sulfide-d4.html HYPERLINK https:/www.MedChemE/lansoprazole-sulfide-d4.html D4Cat. No.: HY-W013186SLansoprazole (AG 1749) is an orally active protonpump inhibito
47、r which prevents the stomach fromproducing acid. Lansoprazole (AG 1749) is a potentbrain penetrant neutral sphingomyelinase(N-SMase) inhibitor (exosome inhibitor).Lansoprazole Sulfide D4 is a deuterium labeledLansoprazole Sulfide. Lansoprazole Sulfide is anactive metabolite of the proton pump inhibi
48、torLansoprazole.Purity: 98.0%Clinical Data: LaunchedSize: 10 mM 1 mL, 500 mg, 1 g, 5 gPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/lansoprazole-d4.html Lansoprazole-d4 HYPERLINK https:/www.MedChemE/lansoprazole-d4.html HYPERLINK https:/www.MedChemE/
49、AZD0865.html Linaprazan(AG-1749-d4) Cat. No.: HY-13662S (AZD0865) Cat. No.: HY-100412Lansoprazole D4 (AG-1749 D4) is a deuteriumlabeled Lansoprazole. Lansoprazole is a protonpump inhibitor which prevents the stomach fromproducing acid.Linaprazan (AZD0865) inhibits gastric H+,K+-ATPaseby K+-competiti
50、ve binding. (IC50: 1.0 0.2 M) Itis a acid-suppressing agents with rapid onset ofaction and potent acid inhibition. In vitro:Linaprazan can inhibit the final step in acidsecretion.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 98.80%Clinical Data: Phase 2Size: 10 mM 1
51、 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/manzamine-a-hydrochloride.html Manzamine HYPERLINK https:/www.MedChemE/manzamine-a-hydrochloride.html HYPERLINK https:/www.MedChemE/manzamine-a-hydrochloride.html A HYPERLINK https:/www.MedChemE/manzamine-a-hydrochloride.html HYPER
52、LINK https:/www.MedChemE/manzamine-a-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/manzamine-a-hydrochloride.html HYPERLINK https:/www.MedChemE/Omeprazole.html OmeprazoleCat. No.: HY-117025A(H 16868) Cat. No.: HY-B0113Manzamine A hydrochloride, an orally activebeta-carboline alkaloi
53、d, inhibits specificallyGSK-3 and CDK-5 with IC s of 10.2 M and 1.550M, respectively. Manzamine A hydrochloridetargets vacuolar ATPases and inhibits autophagyin pancreatic cancer cells.Omeprazole (H 16868), a proton pump inhibitor(PPI), is available for treatment of acid-relatedgastrointestinal diso
54、rders. Omeprazole showscompetitive inhibition of CYP2C19 activity with aK of 2 to 6 M.iPurity: 99.29%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.19%Clinical Data: LaunchedSize: 10 mM 1 mL, 100 mg, 500 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/
55、www.MedChemE/omeprazole-sodium.html Omeprazole HYPERLINK https:/www.MedChemE/omeprazole-sodium.html HYPERLINK https:/www.MedChemE/omeprazole-sodium.html sodium(H 16868 sodium) Cat. No.: HY-B0113A HYPERLINK https:/www.MedChemE/omeprazole-13cd3.html Omeprazole-13CD3(H 16868-13CD3) Cat. No.: HY-B0113S3
56、Omeprazole sodium (H 16868 sodium), a protonpump inhibitor (PPI), is available fortreatment of acid-related gastrointestinaldisorders. Omeprazole sodium shows competitiveinhibition of CYP2C19 activity with a K of 2 toi6 M.Omeprazole-13CD3 (H 16868-13CD3) is a 13C-labeledand deuterium labeled Omepraz
57、ole. Omeprazole (H16868), a proton pump inhibitor (PPI), isavailable for treatment of acid-relatedgastrointestinal disorders.Purity: 98.03%Clinical Data: LaunchedSize: 10 mM 1 mL, 100 mg, 500 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/Ome
58、prazole-D3.html Omeprazole-d3(H 16868-d3) Cat. No.: HY-B0113S HYPERLINK https:/www.MedChemE/omeprazole-d3-1.html Omeprazole-d3-1(H 16868-d3-1) Cat. No.: HY-B0113S1Omeprazole D3 (H 16868 D3) is deuterium labeledOmeprazole. Omeprazole, a proton pumpinhibitor (PPI), is available for treatment ofacid-re
59、lated gastrointestinal disorders.Omeprazole-d3-1 (H 16868-d3-1) is the deuteriumlabeled Omeprazole. Omeprazole (H 16868), aproton pump inhibitor (PPI), is available fortreatment of acid-related gastrointestinaldisorders.Purity: 98.99%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurit
60、y: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/pantoprazole.html Pantoprazole(BY1023; SKF96022) Cat. No.: HY-17507 HYPERLINK https:/www.MedChemE/Pantoprazole-sodium.html Pantoprazole HYPERLINK https:/www.MedChemE/Pantoprazole-sodium.html HYPERLINK h
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 機關廉政活動方案
- (2025年)甘肅省張掖市【輔警協警】筆試模擬考試試題含答案
- (2025年)甘肅省白銀市輔警協警筆試筆試預測試題含答案
- 2025至2030ABS傳感器行業市場占有率及投資前景評估規劃報告
- 曲藝協會內部活動方案
- 景區尋寶活動方案
- 最美all活動策劃方案
- 楓橋景區活動方案
- 最佳校友評比活動方案
- 智慧社區項目活動方案
- 2024-2025學年度天津鐵道職業技術學院單招《語文》真題附答案詳解(突破訓練)
- 2025年育嬰師職業資格考試試題及答案
- 2023年三種人試題附答案
- 北京市八十中學2025屆八年級英語第二學期期中經典試題含答案
- 2024年 金澤鎮專職村務工作者招錄考試真題試題含答案
- 哇哈哈品牌管理制度
- 2025年內蒙古自治區包頭市東河區第二中學英語八年級第二學期期末復習檢測模擬試題含答案
- 2025年四川省達州市中考英語真題(原卷版)
- 2025-2026年中國臺球產業消費趨勢報告
- 2024年證券市場基本法律法規真題及答案
- 湖南省2025年高考公安院校公安專業考生檔案審核表
評論
0/150
提交評論